Roland Berger

Global Topics

Featured
It's time to rethink AI
As our lives and work are increasingly being reshaped by AI, the new edition of Think:Act Magazine explores what this means for C-level managers.

Macroeconomic & Geopolitical Analyses
Roland Berger provides you latest insights and analyses to help our clients navigate macroeconomic complexity and geopolitical shifts.

Roland Berger Trend Compendium 2050
The Roland Berger Trend Compendium 2050 covers six megatrends shaping the world between now and 2050.

Latest
German economic outlook in the second half of 2024

Due to weak business prospects and geopolitical uncertainty, the German economy barely manages to overcome stagnation in 2024.
The future of reinsurance

Adapting to emerging risks and operational challenges.
AI in operations: The key success factors

How industry leaders leverage AI to boost next generation manufacturing & operations.
All Global Topics

Browse all insights

Our Company

Upcoming International Events
- September 10, 2024
  
  EV Charging Index 2024 – author Q&A
  
  Our collegues Juan Luis Vilchez, Adam Healy, Erin Sowerby, and Jack Zhuang organize two virtual events on the topic of "EV Charging Index 2024 – Author Q&A", on September 10th or September 16th. Gain valuable insights into global EV trends and benefit from our expert knowledge. For more information, please find it here.
More Events

Recent Events

Portrait of Salil Churi

Salil Churi

Principal

, North America

+13 12 662-5513

Back to location

Expertise

Pharma & Healthcare

Publications

US pharmaceutical pricing at a crossroads

Filip Conic, Matthias Buente, Morris Hosseini, Salil Churi

Article, February 5, 2024

Robotics in surgery

Marco Bühren, Matthias Buente, Salil Churi, Thilo Kaltenbach, Peter Magunia

STUDY, June 13, 2023

Mastering supply chain crises in the pharmaceutical industry

Thilo Kaltenbach, Stephan Fath

Article, July 11, 2022

Future of health 3 - How the phygital model is going to transform healthcare

Karsten Neumann, Oliver Rong, Ulrich Kleipaß, Thilo Kaltenbach, Morris Hosseini

Study, September 24, 2021

Load More

Load More